Impact of fibroblast growth factor 21 on the secretome of human perivascular preadipocytes and adipocytes: a targeted proteomics approach

Archives of Physiology and Biochemistry

Volumn 122, Issue 5, 2016, Pages 281-288

  Berti, Lucia ^a,b,c   Hartwig, Sonja ^c,d   Irmler, Martin ^b,c   Rädle, Bernhard ^b,c   Siegel Axel, Dorothea ^a,c,e   Beckers, Johannes ^b,c,f   Lehr, Stefan ^c,d   Al Hasani, Hadi ^c,d   Häring, Hans Ulrich ^a,c,e   Hrabě de Angelis, Martin ^b,c,f   Staiger, Harald ^a,c,e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adipokines; atherosclerosis; cardiovascular disease; obesity; subclinical inflammation

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21;

ADIPOCYTE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN GENOME; INFLAMMATION; METABOLISM; PATHOLOGY; PROCEDURES; PROTEOMICS; RADIAL ARTERY; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; BIOMARKERS; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; INFLAMMATION; PROTEOMICS; RADIAL ARTERY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84982862212     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813455.2016.1212898     Document Type: Article

References (42)

1. Auguet T, Quintero Y, Riesco D, et al (2011). New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet, 12:60
2. Berti L, Irmler M, Zdichavsky M, et al (2015). Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab, 4:519–27
3. Bobbert T, Schwarz F, Fischer-Rosinsky A, et al (2013). Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care, 36:145–9
4. Böhm A, Halama A, Meile T, et al (2014). Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals. PLoS One, 9:e93148
5. Brown NK, Zhou Z, Zhang J, et al (2014). Perivascular adipose tissue in vascular function and disease:A review of current research and animal models. Arterioscler Thromb Vasc Biol, 34:1621–30
6. Chatterjee TK, Aronow BJ, Tong WS, et al (2013). Human coronary artery perivascular adipocytes overexpress genes responsible for regulating vascular morphology, inflammation, and hemostasis. Physiol Genomics, 45:697–709
7. Chung S, Lapoint K, Martinez K, et al (2006). Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology, 147:5340–51
8. de Souza Batista CM, Yang RZ, Lee MJ, et al (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56:1655–61
9. Ding X, Boney-Montoya J, Owen BM, et al (2012). βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab, 16:387–93
10. Hiramatsu-Ito M, Shibata R, Ohashi K, et al (2016). Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc Res, 110:107–17
11. Jialal I, Devaraj S, Kaur H, et al (2013). Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab, 98:E514–7
12. Karelis AD, Brochu M, Rabasa-Lhoret R, et al (2004). Clinical markers for the identification of metabolically healthy but obese individuals. Diabetes Obes Metab, 6:456–7
13. Karelis AD, Rabasa-Lhoret R., (2008). Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab, 34:183–4
14. Koska J, Sands M, Burciu C, Reaven P., (2015). Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes. Diab Vasc Dis Res, 12:154–63
15. Kucur M, Isman FK, Karadag B, et al (2007). Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis, 18:391–6
16. Lamers D, Famulla S, Wronkowitz N, et al (2011). Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes, 60:1917–25
17. Lehman SJ, Massaro JM, Schlett CL, et al (2010). Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification:The Framingham Heart Study. Atherosclerosis, 210:656–61
18. Liu R, Wang X, Bu P., (2011). Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract, 93:21–5
19. Ma WH, Wang XL, Du YM, et al (2012). Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovasc Disord, 12:35
20. Moe KT, Naylynn TM, Yin NO, et al (2013). Tumor necrosis factor-α induces aortic intima-media thickening via perivascular adipose tissue inflammation. J Vasc Res, 50:228–37
21. Mulvihill EE, Drucker DJ., (2014). Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev, 35:992–1019
22. Ogawa Y, Kurosu H, Yamamoto M, et al (2007). BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci USA, 104:7432–7
23. Omar A, Chatterjee TK, Tang Y, et al (2014). Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol, 34:1631–6
24. Pan HY, Guo L, Li Q., (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract, 88:29–33
25. Rainer J, Sanchez-Cabo F, Stocker G, et al (2006). CARMAweb:Comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res, 34:W498–503
26. Rittig K, Dolderer JH, Balletshofer B, et al (2012). The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia, 55:1514–25
27. Rittig K, Staib K, Machann J, et al (2008). Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia, 51:2093–9
28. Schäffler A, Neumeier M, Herfarth H, et al (2005). Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta, 1732:96–102
29. Sell H, Blüher M, Klöting N, et al (2013). Adipose dipeptidyl peptidase-4 and obesity:Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care, 36:4083–90
30. Shen Y, Ma X, Zhou J, et al (2013). Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovasc Diabetol, 12:124
31. Siegel-Axel DI, Häring HU., (2016). Perivascular adipose tissue:An unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord, 17:51–60
32. Siegel-Axel DI, Ullrich S, Stefan N, et al (2014). Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells. Diabetologia, 57:1057–66
33. Sims EA., (2001). Are there persons who are obese, but metabolically healthy? Metab Clin Exp, 50:1499–504
34. Stefan N, Hennige AM, Staiger H, et al (2006). Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 29:853–7
35. Stefan N, Kantartzis K, Machann J, et al (2008). Identification and characterization of metabolically benign obesity in humans. Arch Intern Med, 168:1609–16
36. Szasz T, Bomfim GF, Webb RC., (2013). The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag, 9:105–16
37. Tomiyama K, Maeda R, Urakawa I, et al (2010). Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci USA, 107:1666–71
38. van Harmelen V, Skurk T, Röhrig K, et al (2003). Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord, 27:889–95
39. van Hinsbergh VW, Eringa EC, Daemen MJ., (2015). Neovascularization of the atherosclerotic plaque:Interplay between atherosclerotic lesion, adventitia-derived microvessels and perivascular fat. Curr Opin Lipidol, 26:405–11
40. Wang P, Xu TY, Guan YF, et al (2009). Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor:Role of nicotinamide mononucleotide. Cardiovasc Res, 81:370–80
41. Wu X, Qi YF, Chang JR, et al (2015). Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(−/−) mice. Heart Vessels, 30:657–68
42. Yang RZ, Lee MJ, Hu H, et al (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue:Possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 290:E1253–61